Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Richard Stark
 2. Date of Event Requiring Statement (Month/Day/Year)
01/03/2012		 3. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ANGO]
(Last)
(First)
(Middle)
603 QUEENSBURY AVENUE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, GM - Oncology
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

QUEENSBURY, NY 12804		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 3,502
D
 
Common Stock 4,000 (1)
D
 
Common Stock 3,000 (2)
D
 
Common Stock 4,000 (3)
D
 
Common Stock 8,500 (4)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   (5) 08/06/2015 Common Stock 18,100 $ 15.27 D  
Non-Qualified Stock Option (right to buy)   (6) 09/04/2016 Common Stock 8,500 $ 13.29 D  
Non-Qualified Stock Option (right to buy)   (7) 10/22/2014 Common Stock 9,300 $ 20.59 D  
Non-Qualified Stock Option (right to buy) 08/11/2010 08/11/2016 Common Stock 5,166 $ 18.93 D  
Non-Qualified Stock Option (right to buy)   (8) 08/05/2014 Common Stock 4,305 $ 20.32 D  
Non-Qualified Stock Option (right to buy) 12/23/2009 12/23/2015 Common Stock 2,152 $ 23.11 D  
Non-Qualified Stock Option (right to buy)   (9) 10/02/2013 Common Stock 1,765 $ 17.59 D  
Non-Qualified Stock Option (right to buy)   (10) 08/23/2012 Common Stock 688 $ 32.17 D  
Non-Qualified Stock Option (right to buy)   (11) 04/01/2012 Common Stock 258 $ 55.28 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Richard Stark
603 QUEENSBURY AVENUE
QUEENSBURY, NY 12804		       SVP, GM - Oncology  

Signatures

/s/ Stephen A. Trowbridge, Attorney in Fact 01/12/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents 4,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in equal installments on 09/04/2012 and 09/04/2013.
(2) Represents 3,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in equal installments on 08/03/2012, 08/03/2013 and 08/03/2014.
(3) Represents 4,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 01/28/2012.
(4) Represents 8,500 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 08/03/2012.
(5) Options for 25% of the shares are exercisable on 08/06/2009, 08/06/2010, 08/06/2011 and 08/06/2012.
(6) Options for 25% of the shares are exercisable on 09/04/2010, 09/04/2011, 09/04/2012 and 09/04/2013.
(7) Options for 25% of the shares are exercisable on 10/22/2008, 10/22/2009, 10/22/2010 and 10/22/2011.
(8) Options for 539 of the shares became exercisable on 02/05/2005 and options for 3,766 of the shares became exercisable on 08/05/2008.
(9) Options for 221 of the shares became exercisable on 04/02/2004 and options for 1,544 of the shares became exercisable on 10/02/2007.
(10) Options for 86 of the shares became exercisable on 02/23/2003 and options for 602 of the shares became exercisable on 08/23/2006.
(11) Options for 33 of the shares became exercisable on 10/01/2002 and options for 225 of the shares became exercisable on 04/01/2006.
 
Remarks:
Exhibit List:  Exhibit 24.1 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.